Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 413 - Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
Patents for C07D 413 - Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms (64,687)
05/2005
05/24/2005US6897198 Method of treatment with combinations of statin and aryl-substituted propanolamine derivatives
05/24/2005CA2169194C Substituted azadioxacycloalkenes and their use as fungicides
05/24/2005CA2157792C N-(3-piperidinyl-carbonyl)-beta-alanine derivatives as paf antagonists
05/24/2005CA2155840C Hydroxymethyl furazane carboxylic acid derivatives and their use in the treatment of cardio-vascular conditions
05/19/2005WO2005044797A1 Allosteric modulators of metabotropic glutamate receptors
05/19/2005WO2005044192A2 Triazole compounds and uses related thereto
05/19/2005WO2005030140A3 C-met modulators and methods of use
05/19/2005WO2005028436A3 Thalidomide analogs as tnf-alpha modulators
05/19/2005WO2005000840A8 Substituted diketopiperazines and their use as oxytocin antagonists
05/19/2005WO2004103279A3 3-(2-amino-1-azacyclyl)-5-aryl-1,2,4-oxadiazoles as s1p receptor agonists
05/19/2005WO2004028540A9 Anti-neurodegenerative agents
05/19/2005WO2003049678A3 Mitotic kinesin inhibitors
05/19/2005US20050107616 Alpha-ketoamide derivatives as cathepsin k inhibitors
05/19/2005US20050107457 Indazole derivatives as JNK inhibitors and compositions and methods related thereto
05/19/2005US20050107456 such as N-(4-phenyl)-3-(4-chlorophenyl)-4-(4-cyanopyrazol-1-yl)-4,5-dihydro-1-pyrazolecarboxanilide, optionally mixed with extenders and/or surfactants, used for controlling pests
05/19/2005US20050107449 Substituted thiazoles and oxazoles, e.g., 4-{1-[4-[2-(2-Chloro-6-fluoro-phenyl)-ethyl]-2-(4-trifluoromethyl-phenyl)-thiazol-5-yl]-ethylsulfanyl}-2-methyl-phenoxy)-acetic acid; treating atherosclerosis and diabetes and creating Syndrome X
05/19/2005US20050107435 antibiotics such as (5S,5S')-N-(3-{4'-[5-(Acetylamino-methyl)-2-oxo-oxazolidin-3-yl]-2,2'-difluoro-biphenyl-4-yl}-2-oxo-oxazolidin-5-ylmethyl)-acetamide, used for treating a bacterial infections in mammals
05/19/2005US20050107431 Piperidinylchromen-6-ylsulfonamide compounds as 5-hydroxytryptamine-6 ligands
05/19/2005US20050107428 Antiinflammatory agents; autoimmune diseases; rheumatic diseases; anticholesterol agents; cardiovascular disorders
05/19/2005US20050107423 Quinolone antibiotics such as 1-Cyclopropyl-6-fluoro-7-(4-hydroxy-hexahydro-cyclopenta[c]pyrrol-2-yl)-8-methyl-4-oxo-1,4-dihydro-quinoline-3-carboxylic acid, used for treating gramnegative or grampositive bacterial infection in mammals
05/19/2005US20050107414 enzyme inhibitors such as N-(4-{4-[5-(2-Ethoxy-ethyl)-2,4,6-trioxo-hexahydro-pyrimidin-5-yloxy]-phenoxy}-benzyl)-acetamide, used for treating inflammation, cancers and other disorders
05/19/2005US20050107410 Compound possessing affinity at 5ht1-type receptors and use thereof in therapy of cns disorders
05/19/2005US20050107404 Mitotic kinesin inhibitors
05/19/2005US20050107396 for the treatment of psychotic disorders and Parkinson's disease; crystalline polymorph
05/19/2005US20050107392 treatment of disease such as diabetes, obesity, hyperlipidemia, and atherosclerotic disease; e.g. ethyl (5-methoxy-2,3-dihydro-1H-inden-1-ylidene)ethanoate
05/19/2005US20050107389 Novel heterocyclic amide derivatives and their use as dopamine D3 receptor ligands
05/19/2005US20050107388 Heteroaromatic urea derivatives as vr-1receptor modulators for treating pain
05/19/2005US20050107384 to inhibit proliferative conditions, such as cancer and psoriasis; detecting or identifying a HDAC in a biological sample comprising detecting or measuring the formation of a complex between a labelled compound as defined in claim (I) and a HDAC
05/19/2005US20050107381 e.g. 2-[2-(3,5-Difluoro-phenyl)-acetylamino]-N-pyridin-2-yl-butyramide; inhibiting A beta -production; Alzheimer's disease, hereditary cerebral hemorrhage with amyloidosis, cerebral amyloid angiopathy, a prion-mediated disease, inclusion body myositis, stroke, multiple sclerosis and Down's Syndrome
05/19/2005US20050107379 antithrombolytic agents such as (E)-2-(5-Chlorothien-2-yl)-N-{(3S)-1-[(1S)-1-methyl-2-morpholin-4-yl-2-oxoethyl]-2-oxopyrrolidin-3-yl}ethenesulfonamide, used for therapy of cardiovascular disorders
05/19/2005US20050107371 reduction of glucose, insulin, free fatty acids; treatment, control and prevention of diabetes, obesity, atherosclerosis, vascular inflammation and their related diseases; e.g. 7-[2-(5-Methyl-2-phenyl-4-oxazolyl)ethoxy]chromane-3-carboxylic Acid
05/19/2005US20050107369 Heteroaromatic selective inhibitors of neuronal nitric oxide synthase
05/19/2005US20050107368 Inhibitors of cathepsin S
05/19/2005US20050107362 Indolamid derivatives which possess glycogenphosphorylase inhibitory activity
05/19/2005US20050107358 Such as 4-[(3-chloro-4-fluoro-phenyl)amino]-6-{[4-(homomorpholin-4-yl)-1-oxo-2-buten-1-yl]amino}-7-[(S)-(tetrahydrofuran-3-yl)oxy]-quinazoline; inhibiting signal transduction by tyrosine kinases; treating tumoral diseases and benign prostatic hyperplasia, and diseases of lungs and respiratory tract
05/19/2005US20050107257 Derivatives of (1-benzyl-piperidine-4-yl)-diphenyl-methanol and their use as pesticide
05/19/2005DE10348554A1 Verwendung einer Verbindung aus der Gruppe der Heterodiazole oder eines Salzes der Verbindung, die Verbindung oder das Salz enthaltende kosmetische oder therapeutische Formulierung, die Verbindung oder das Salz als therapeutisches Mittel sowie das Salz selbst Use of a compound from the group of heterodiazoles or a salt of the compound, the compound or the salt-containing cosmetic or therapeutic formulation, the compound or the salt as a therapeutic agent as well as the salt itself
05/19/2005DE10348023A1 Neue Alanyl-Aminopeptidasen-Inhibitoren zur funktionellen Beeinflussung unterschiedlicher Zellen und zur Behandlung immunologischer, entzündlicher, neuronaler und anderer Erkrankungen New alanyl aminopeptidase inhibitors for functional interference of different cells and for the treatment of immunological, inflammatory, neuronal and other diseases
05/19/2005CA2544748A1 Allosteric modulators of metabotropic glutamate receptors
05/19/2005CA2543602A1 Triazole compounds and uses related thereto
05/18/2005EP1530569A2 Pyridyl substituted heterocycles useful for treating or preventing hcv infection
05/18/2005EP1530568A1 INDOLE OR BENZIMIDAZOLE DERIVATIVES FOR MODULATING I&kB KINASE
05/18/2005EP1530472A1 Isoquinoline derivatives as matrix metalloproteinase inhibitors
05/18/2005EP1530468A1 Substituted isoxazole derivatives and their use in pharmaceutics
05/18/2005EP1176139B1 Medicinal compositions with 2.2.1] and 3.1.1] bicycloskeleton antagonistic to both of pgd 2?/txa 2? receptors
05/18/2005CN1617858A Pyrimidine derivatives as modulators of insulin-like growth factor-1 receptor (igf-1)
05/18/2005CN1617855A Inhibitors of cytosolic phospholipase A2
05/18/2005CN1617852A Alpha-(n-sulphonamido)acetamide derivatives as beta-amyloid inhibitors
05/18/2005CN1617849A Hiv整合酶抑制剂 Hiv integrase inhibitors
05/18/2005CN1617718A N-aryl-N'-arylcycloalkyl-urea derivatives as MCH antagonists for the treatment of obesity
05/18/2005CN1617712A Pharmaceutical nanoparticulate composition of a tachykinin receptor antagonist
05/18/2005CN1616458A Light-emitting compound and luminescent element
05/18/2005CN1202095C Heteroaromatic ring compounds
05/18/2005CN1202093C Substituted heterocyclic compound
05/17/2005US6894177 Viricides; human immunodeficiency virus
05/17/2005US6894065 For therapy of thrombosis, platelet aggregation, coagulation, cancer, inflammatory diseases or respiratory diseases
05/17/2005US6894046 For treating eosinophil-dependent inflammatory diseases, asthma
05/17/2005US6894005 Heterocyclic compound containing phenyl groups; postemergence herbicides
05/17/2005US6893859 Antiproliferative agent for treating diseases or conditions characterized by cellular hyperproliferation
05/17/2005US6892568 Noise detection system and method
05/17/2005CA2301967C Azetidinone derivatives for the treatment of hcmv infections
05/17/2005CA2301543C Azetidinone derivatives for the treatment of hcmv infections
05/17/2005CA2252907C Novel 2,3 disubstituted-4(3h)-quinazolinones
05/17/2005CA2125549C Tetrazole derivatives, their production and use
05/12/2005WO2005042523A1 A novel oxazolidinone derivative and manufacturing process thereof
05/12/2005WO2005042521A2 Piperidinyl-and piperazinyl-sulfonylmethyl hydroxamic acids and their use as protease inhibitors
05/12/2005WO2005042517A2 Bipiperidinyl derivatives useful as inhibitors of chemokine receptors
05/12/2005WO2005042516A2 Ligands of melanocortin receptors and compositions and methods related thereto
05/12/2005WO2005042504A1 Fluorinated resorufin compounds and their application in detecting hydrogen peroxide
05/12/2005WO2005042502A1 Amide derivatives
05/12/2005WO2005042499A1 Processes for production of pyrimidine derivatives and intermediates
05/12/2005WO2005042497A2 Benzimidazoles useful as modulators of ion channels
05/12/2005WO2005042489A1 N-substituted benzene sulfonamides
05/12/2005WO2005042488A1 Pyridine compounds as inhibitors of dipeptidyl peptidase iv
05/12/2005WO2005041888A2 Pyrimidin-4-one compounds, compositions and methods
05/12/2005WO2005030131A3 Bis-quinazoline compounds for the treatment of bacterial infections
05/12/2005WO2005018644B1 Capped pyrazinoylguanidine sodium channel blockers
05/12/2005WO2005018531A3 Pharmaceutical compositions, azo-heterocyclic compounds and method for the production and use thereof
05/12/2005WO2005014539A3 Pyrrole-based hmg-coa reductase inhibitors
05/12/2005WO2005003099A3 Pyrimidines useful as modulators of voltage-gated ion channels
05/12/2005WO2004092145A8 Alpha substituted carboxylic acid as ppar modulators
05/12/2005US20050101664 Anionically coupling an acyl imidazoyl carbamate with a primary amide or carbamate; N-alkylation; inosine-5*-monophosphate dehydrogenase inhibitors
05/12/2005US20050101657 Pyrrole derivatives for preventing or treating cancer sensitive to hormones; administered with luteininzing hormone releasing hormone derivative
05/12/2005US20050101651 Viricides; protease inbhibitors; useful for inhibiting the activity of picornaviral 3C proteases; for example, 6-carbamoyl-4S-{2S-[(5-naphthalen-1-yl-1H-pyrrole-2-carbonyl)-amino-3-phenyl-propionylamino}-hex-2(trans)-enoic acid ethyl ester
05/12/2005US20050101650 (4-(4-(2,3-difluorophenyl)-4H-1,2,4-triazol-3-yl)-1H-pyrrol-2-yl)(2H-pyrrol-1(5H)-yl)methanone; anticarcinogenic, antiproliferative and antimetastasis agent; inhibitors of c-Met protein kinase
05/12/2005US20050101647 For example, 2-(1,3-benzodioxol-5-yl)-6-phenyl-1H-imidazo[4,5-b]pyridinetyrosine; kinase-inhibiting activity; use in treatment of breast cancer, prostate cancer, lung cancer or pancreatic carcinoma
05/12/2005US20050101641 Aromatic sulfone hydroxamic acids and their use as protease inhibitors
05/12/2005US20050101637 Cycloalkylmethoxy-substituted acetic acid derivatives, processes for their preparation and their use as pharmaceuticals
05/12/2005US20050101636 PPAR-activating compound and pharmaceutical composition comprising the compound
05/12/2005US20050101630 4-Anilino-, phenoxy-, or phenylthio-substituted; inhibitors of specific kinase enzymes, such as MEK enzymes
05/12/2005US20050101616 Quinazoline analogs as receptor tyrosine kinase inhibitors
05/12/2005US20050101590 Cannabinoid receptor agonists
05/12/2005US20050101586 Novel 5-HT2A receptor ligands
05/12/2005US20050101567 Using a sulfonamide containing compound
05/12/2005CA2544377A1 Bipiperidinyl derivatives useful as inhibitors of chemokine receptors
05/12/2005CA2544350A1 N-substituted benzene sulfonamides
05/12/2005CA2543918A1 Benzimidazoles useful as modulators of ion channels
05/12/2005CA2543715A1 Piperidinyl-and piperazinyl-sulfonylmethyl hydroxamic acids and their use as protease inhibitors
05/12/2005CA2543529A1 Pyridine compounds as inhibitors of dipeptidyl peptidase iv
05/11/2005EP1529530A1 Compounds affecting glucokinase
1 ... 365 366 367 368 369 370 371 372 373 374 375 376 377 378 379 380 381 382 383 384 385 ... 647